CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,095 | -58.0% | 377,593 | -44.0% | 0.00% | -50.0% |
| Q2 2023 | $1,160,142 | +5.3% | 674,501 | -7.6% | 0.00% | 0.0% |
| Q1 2023 | $1,102,206 | +1800.4% | 729,938 | +1723.9% | 0.00% | – |
| Q3 2022 | $58,000 | -50.8% | 40,021 | -37.6% | 0.00% | – |
| Q2 2022 | $118,000 | +195.0% | 64,144 | +320.2% | 0.00% | – |
| Q1 2022 | $40,000 | -95.6% | 15,266 | -87.0% | 0.00% | -100.0% |
| Q1 2020 | $900,000 | -73.0% | 117,393 | -70.8% | 0.01% | -60.9% |
| Q4 2019 | $3,336,000 | +5554.2% | 401,426 | +4902.2% | 0.02% | – |
| Q3 2019 | $59,000 | -92.5% | 8,025 | -84.5% | 0.00% | -100.0% |
| Q4 2018 | $783,000 | -73.7% | 51,876 | -67.7% | 0.01% | -38.5% |
| Q3 2018 | $2,976,000 | +765.1% | 160,816 | +1229.1% | 0.01% | -7.1% |
| Q1 2018 | $344,000 | – | 12,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |